ESGO-ESTRO-ESP 2023 Update of the Cervical Cancer Guidelines The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) completed the updating process of the Cervical Cancer Guidelines. The international development group of experts in gynaecological oncology, radiation oncology, medical oncology, pathology and palliative care worked under the chairmanship of Prof. David Cibula (ESGO), Prof. Jacob Christian Lindegaard (ESTRO) and Prof. Maria Rosaria Raspollini (ESP). The article was published in International Journal of Gynaecologic Cancer (IJGC) on 1 May, 2023. 2023 Update of the Cervical Cancer Guidelines article: ESGO-ESTRO-ESP Cervical cancer guidelines - 2023 Update Cervical Cancer Pocket Guidelines 2023 ESGO-ESTRO-ESP Cervical Cancer Guidelines Working Group The European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) would like to express their sincere gratitude to the international experts panel, who devoted their time and effort to the ESGO-ESTRO-ESP Guidelines for the Management of Patients with Cervical Cancer. Name Country Institution David Cibula Czech Rep. Department of Obstetrics and Gynecology, Charles University, First Faculty of Medicine, Prague, Czech Republic; General University Hospital in Prague, Prague, Czech Republic Jacob Lindegaard Denmark Aarhus University Hospital, Aarhus, Denmark Maria Rosaria Raspollini Italy University Hospital Careggi, Firenze, Italy Francois Planchamp France Clinical Research Unit, Institut Bergonie, Bordeaux, France Carlos Centeno Spain Department of Palliative Medicine, University of Navarra, Pamplona, Spain Cyrus Chargari France Service d’Oncologie Radiothérapie, Hôpital Universitaire Pitié Salpêtrière, Paris, France Ana Felix Portugal Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE, Lisboa, Portugal Daniela Fischerova Czech Rep. Department of Obstetrics and Gynecology, Charles University, First Faculty of Medicine, Prague, Czech Republic; General University Hospital in Prague, Prague, Czech Republic Daniela Jahn-Kuch Austria Department of Internal Medicine, Medical University of Graz, Graz, Austria Florence Joly France François Baclesse Centre de Lutte Contre le Cancer, Caen, France Christhardt Kohler Germany Asklepios Clinic Altona, Hamburg, Germany; Asklepios Comprehensive Tumor Center, Hamburg, Germany Sigurd Lax Austria Hospital Graz II, Graz, Austria; 14Johannes Kepler Universitat Linz, Linz, Austria; Domenica Lorusso Italy Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy Catholic University of Sacred Heart, Rome, Italy Umesh Mahantshetty India Homi Bhabha Cancer Hospital and Research Centre, Visakhapatnam, Andhra Pradesh, India Patrice Mathevet Switzerland CHUV, Lausanne, Switzerland Raj Naik UK Northern Gynaecological Oncology Centre, Gateshead, UK Remi Nout The Netherlands Radiotherapy, Erasmus MC Cancer Centre, Rotterdam, The Netherlands; University Medical Center, Rotterdam, The Netherlands Ana Oaknin Spain Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Hospital Universitari Vall d'Hebron, Barcelona, Spain Fedro Peccatori Italy European Institute of Oncology IRCCS, Milan, Italy Jan Persson Sweden Department of Obstetrics and Gynecology, Lund University Hosptial, Lund, Sweden; Skåne University Hospital Lund, Lund, Sweden Denis Querleu France University Hospitals Strasbourg, Strasbourg, France Sandra Rubio Bernabe Spain Medical Oncology, Clinica Universidad de Navarra, Pamplona, Spain Maximilian Schmid Austria Department of Radiation Oncology, Medical University of Vienna, Wien, Austria Artem Stepanyan Armenia Gynecologic Oncology, Nairi Medical Center, Yerevan, Armenia Valentyn Svintsitskyi Ukraine National Cancer Institute, Kiev, Ukraine Karl Tamussino Austria Medical University of Graz, Graz, Austria Ignacio Zapardiel Spain Gynecologic Oncology, La Paz University Hospital, Madrid, Spain External Reviewers 148 reviewers - 39 countries ESGO would also like to thank external reviewers who have taken the time to provide their feedback on the document elaborated in the framework of the ESGO-ESTRO-ESP Guidelines for the Management of the Cervical Cancer Project. -> List of external reviewers ESGO Algorithms App Get started and download the ESGO Algorithms App! Available for iPhone, iPad and Android Devices.